Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740655
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal SurgeryJeju National University School of MedicineNot Yet RecruitingPhase 4
NCT07740655Not Yet Recruiting
Phase 4
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation...Jeju National University...
NCT07739576
Descriptions and Practices of Family Engagement in Emergency Care SettingMayo ClinicNot Yet Recruiting
NCT07739576Not Yet Recruiting
—
Descriptions and Practices of Family Engagement in Emergency Care SettingMayo Clinic
NCT07739862
Acceleromyography Versus Electromyography for Neuromuscular Recovery Assessment at the End of SurgeryClínica DávilaNot Yet Recruiting
NCT07739862Not Yet Recruiting
—
Acceleromyography Versus Electromyography for Neuromuscular Recovery Assessment...Clínica Dávila
NCT07738952
Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum DisorderKyushu UniversityNot Yet RecruitingPhase 1
NCT07738952Not Yet Recruiting
Phase 1
Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorde...Kyushu University
NCT07740486
A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable DiseaseJohnson & JohnsonNot Yet RecruitingPhase 3
NCT07740486Not Yet Recruiting
Phase 3
A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab...Johnson & Johnson
NCT07738978
Understanding and Enhancing Human Health and MovementLouis Stokes VA Medical CenterRecruitingNot Applicable
NCT07738978Recruiting
Not Applicable
Understanding and Enhancing Human Health and MovementLouis Stokes VA Medical C...
NCT07738796
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associated Acute Kidney Injury Based on the Gut-Kidney Axis, Incorporating Gut Microbiota and Their MetabolitesPeking Union Medical College HospitalNot Yet Recruiting
NCT07738796Not Yet Recruiting
—
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associ...Peking Union Medical Coll...
NCT07739823
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric PatientMcGill University Health Centre/Research Institute of the McGill University Health CentreNot Yet Recruiting
NCT07739823Not Yet Recruiting
—
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric PatientMcGill University Health...
NCT07739771
Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.Clínica VilaboaNot Yet Recruiting
NCT07739771Not Yet Recruiting
—
Retrospective Observational Study of Oral Complications and Quality of Life in H...Clínica Vilaboa
NCT07740538
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy UniversityNot Yet Recruiting
NCT07740538Not Yet Recruiting
—
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy Universit...
NCT07739784
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.McGill University Health Centre/Research Institute of the McGill University Health CentreRecruiting
NCT07739784Recruiting
—
This Study Examines Whether Personality Traits Influence the Frequency or Severi...McGill University Health...
NCT07740369
An Exploration of Family Centred Care (FCC) in UK Inpatient WardsMilton Keynes University Hospital NHS Foundation TrustRecruiting
NCT07740369Recruiting
—
An Exploration of Family Centred Care (FCC) in UK Inpatient WardsMilton Keynes University...
NCT07738276
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityShahid Beheshti University of Medical SciencesNot Yet RecruitingPhase 3
NCT07738276Not Yet Recruiting
Phase 3
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist,...Shahid Beheshti Universit...
NCT07739290
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney InjuryBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07739290Not Yet Recruiting
Not Applicable
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute...Beth Israel Deaconess Med...
NCT07739277
Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast SurgeryAnkara Etlik City HospitalNot Yet RecruitingNot Applicable
NCT07739277Not Yet Recruiting
Not Applicable
Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast SurgeryAnkara Etlik City Hospita...
NCT07739199
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739199Not Yet Recruiting
Phase 2
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Ver...Baili-Bio (Chengdu) Pharm...
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07738107
ATR 1072 in Participants With PRKAG2 SyndromeAtrium TherapeuticsNot Yet RecruitingPhase 1
NCT07738107Not Yet Recruiting
Phase 1
ATR 1072 in Participants With PRKAG2 SyndromeAtrium Therapeutics
Result Breakdown
Not yet recruiting15 (75%)
Recruiting3 (15%)
Completed2 (10%)
Not Specified8 (40%)
not_applicable4 (20%)
Phase 33 (15%)
Phase 12 (10%)
Phase 22 (10%)
Phase 41 (5%)